Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Acute hepatitis and acute liver failure

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

New encephalopathy with hepatic coagulopathy in a patient without established cirrhosis is acute liver failure until proved otherwise. Contact a specialist liver transplant centre immediately and arrange critical-care management; do not wait for coma, a completed aetiology screen or aminotransferase trends before discussing transfer.

Synopsis

Identify the cause and severity of acute hepatitis, recognise transition to acute liver failure, and escalate early for organ support and transplant-centre assessment.

  • Acute hepatitis is hepatocellular injury developing over days to weeks; causes include viral infection, medicines and toxins, autoimmunity, ischaemia, vascular obstruction, Wilson disease and pregnancy-related syndromes.
  • Aminotransferase height reflects hepatocyte injury, not remaining liver function. INR, glucose, lactate, pH, mental state, renal function and trajectory identify danger.
  • Acute liver failure requires acute liver injury with coagulopathy and hepatic encephalopathy in a person without pre-existing cirrhosis; diagnostic and transplant criteria are specialist protocol decisions.
  • Ask specifically about paracetamol in prescribed, combined cold-and-flu and over-the-counter products, deliberate or staggered ingestion, herbal products, recreational drugs, travel and viral exposures.
  • Send a paracetamol concentration even when ingestion is denied or timing is unclear, and follow current TOXBASE advice because treatment is most effective when started early.
  • Falling ALT is not always recovery: in massive hepatic necrosis it can fall while INR, bilirubin, lactate, creatinine and encephalopathy worsen.
  • Ultrasound with portal and hepatic-vein Doppler looks for biliary obstruction, Budd–Chiari syndrome and chronic liver morphology, but normal imaging does not exclude severe hepatitis.
  • Avoid sedatives and unnecessary correction of INR; frequent neurological, glucose and acid-base monitoring and early transplant-centre dialogue are more important than normalising laboratory numbers.

Key red flags

Acute liver failure

New confusion, altered sleep, asterixis, agitation, somnolence or coma with prolonged INR after acute injury signals failing synthetic and detoxification function and mandates transplant-centre contact.

Hyperacute paracetamol or ischaemic pattern

Very high aminotransferases, early coagulopathy, metabolic acidosis, raised lactate and kidney injury with initially modest jaundice suggest paracetamol toxicity or hypoxic hepatitis; obtain the exposure and haemodynamic history urgently.

Autoimmune hepatitis

Acute jaundice can occur at any age and may have high IgG or autoimmune markers, but serology can be negative. Treatment and biopsy decisions require urgent hepatology input when severe.

Wilson acute failure

A young person with haemolysis, low alkaline phosphatase relative to bilirubin, renal dysfunction or neuropsychiatric clues may have Wilson disease; routine copper markers are imperfect during acute failure and specialist assessment is urgent.

Vascular or pregnancy-associated disease

Painful hepatomegaly, ascites and hepatic-vein obstruction suggest Budd–Chiari; hypertension, haemolysis, thrombocytopenia or late-pregnancy illness raises HELLP or acute fatty liver and needs immediate obstetric-hepatology coordination.

Infection or cerebral deterioration

Fever, hypotension, rising vasopressor need, worsening acidosis, seizures, unequal pupils or decreasing consciousness in liver failure may reflect sepsis or intracranial hypertension and require critical-care intervention.

Investigation priorities

01
Liver panel, INR and albuminFirst step

Define injury pattern and assess hepatic synthetic function.

Management branches

TriageAcute hepatitis severity screen

New marked liver-test abnormality, jaundice or a compatible systemic illness.

  1. Assess ABCDE, mental state and asterixis; check bedside glucose, INR, blood gas, lactate, renal function and urine output alongside the liver panel.
  2. Take a time-anchored exposure history covering every medicine, paracetamol-containing product, supplement, toxin, alcohol or drug use, travel, food, sexual, blood and pregnancy risk.
  3. Stop non-essential potentially hepatotoxic agents, send the structured aetiology screen and ultrasound with Doppler, and discuss severe injury early with hepatology.
  4. Admit and escalate when INR is prolonged, glucose falls, renal function worsens, lactate or acidosis persists, mental state changes, vomiting prevents hydration or diagnostic uncertainty is high.

Key medicines

Intravenous acetylcysteineStart and continue according to current TOXBASE, BNF and local weight-based protocol.Do not delay for a late level or complete history when treatment is indicated. Infusion reactions and fluid volume require monitoring; a reaction does not automatically mean abandoning essential antidote therapy.
Intravenous glucoseTitrate concentrated or maintenance glucose to frequent bedside measurements and critical-care targets.Avoid wide glycaemic swings and fluid overload; monitor potassium, phosphate and sodium, and use a central route when the selected concentration requires it.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BSG adult liver transplantation guidelineUK referral, assessment and transplant pathway principles.
  • BSG abnormal liver blood tests guidelineStructured assessment and aetiology testing.
  • BASL Wilson disease practical guidanceAcute failure presentation and urgent transplant referral.
  • BNF hepatitis treatment summaryUK antiviral and supportive prescribing context.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom